| |
| |
|
| Insider
Information: |
Williams Lewis T |
| Relationship: |
Director |
| City: |
Brea |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
455,336 |
|
|
Indirect Shares
|
2,095,114 |
|
|
| Direct
Value |
$17,302,768 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,550,450 |
|
|
| Total
Value |
$17,302,768 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Beckman Coulter Inc |
BEC |
Director |
2011-06-30 |
0 |
2009-11-02 |
0 |
Premium* |
|
|
Five Prime Therapeutics Inc |
FPRX |
Director |
2019-09-01 |
455,336 |
|
0 |
Premium* |
|
|
Arcellx, Inc. |
ACLX |
Director |
2022-02-08 |
0 |
2022-02-08 |
2,095,114 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2016-04-05 |
4 |
OE |
$8.49 |
$220,307 |
D/D |
25,949 |
366,477 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2016-04-06 |
4 |
OE |
$8.49 |
$227,973 |
D/D |
26,852 |
367,380 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2016-04-14 |
4 |
OE |
$8.49 |
$23,135 |
D/D |
2,725 |
343,253 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2016-04-15 |
4 |
OE |
$8.49 |
$11,928 |
D/D |
1,405 |
341,933 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2016-04-20 |
4 |
OE |
$8.49 |
$4,670 |
D/D |
550 |
341,078 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2016-04-21 |
4 |
OE |
$8.49 |
$408,547 |
D/D |
48,121 |
388,649 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Director |
– • – |
2019-02-05 |
4 |
D |
$11.43 |
$35,936 |
D/D |
(3,144) |
462,286 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Director |
– • – |
2019-02-26 |
4 |
D |
$11.95 |
$11,066 |
D/D |
(926) |
461,360 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President and CEO |
• • – |
2014-10-29 |
4 |
AS |
$13.03 |
$23,783 |
D/D |
(1,825) |
394,944 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President and CEO |
• • – |
2014-10-28 |
4 |
AS |
$13.04 |
$126,911 |
D/D |
(9,734) |
396,769 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President and CEO |
• • – |
2014-11-03 |
4 |
AS |
$13.05 |
$177,007 |
D/D |
(13,559) |
363,646 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President and CEO |
• • – |
2014-10-31 |
4 |
AS |
$13.09 |
$155,752 |
D/D |
(11,901) |
377,205 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President and CEO |
• • – |
2014-11-04 |
4 |
AS |
$13.11 |
$93,650 |
D/D |
(7,143) |
356,503 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President and CEO |
• • – |
2014-10-30 |
4 |
AS |
$13.32 |
$77,779 |
D/D |
(5,838) |
389,106 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Executive Chairman |
• • – |
2018-09-01 |
4 |
D |
$14.00 |
$98,336 |
D/D |
(7,024) |
374,213 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Executive Chairman |
• • – |
2018-02-05 |
4 |
D |
$18.42 |
$57,784 |
D/D |
(3,137) |
376,237 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President and CEO |
• • – |
2015-09-21 |
4 |
AS |
$22.06 |
$58,422 |
D/D |
(2,648) |
366,945 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President and CEO |
• • – |
2015-06-22 |
4 |
AS |
$24.23 |
$1,850,380 |
D/D |
(75,000) |
294,593 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President and CEO |
• • – |
2015-10-15 |
4 |
AS |
$26.68 |
$1,970,509 |
D/D |
(72,352) |
294,593 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President and CEO |
• • – |
2016-02-04 |
4 |
AS |
$32.74 |
$2,375,597 |
D/D |
(71,229) |
340,352 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2017-09-01 |
4 |
D |
$34.34 |
$268,779 |
D/D |
(7,827) |
381,958 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President and CEO |
• • – |
2016-03-02 |
4 |
AS |
$36.01 |
$837,557 |
D/D |
(23,259) |
340,352 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2016-03-29 |
4 |
AS |
$40.01 |
$368,692 |
D/D |
(9,215) |
340,528 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2016-03-30 |
4 |
AS |
$40.02 |
$562,041 |
D/D |
(14,044) |
340,528 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2016-04-05 |
4 |
AS |
$43.00 |
$1,115,807 |
D/D |
(25,949) |
340,528 |
0 |
- |
|
62 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
